ArticleNature communications2024

Targeted transcriptional downregulation of MYC using epigenomic controllers demonstrates antitumor activity in hepatocellular carcinoma models.

William Senapedis et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.